Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September 2004 1 How useful is the Cancer Waiting Times (CWT) dataset.

Slides:



Advertisements
Similar presentations
Pharmacology and the Nursing Process in LPN Practice
Advertisements

High Resolution Italian studies Pamela Minicozzi Descriptive Studies and Health Planning Unit, Department of Preventive and Predictive Medicine, Fondazione.
Booking & Choice Colin Innes Executive Lead Choose and Book.
Peter Johnson On behalf of the CR UK Stratified Medicine Programme Molecular diagnosis of cancer: Making it a reality.
1 TCR TUMOUR MATCHING ALGORITHM The structure of the algorithm- Heather Bourne Using the algorithm - Jason Hiscox.
©2007 World Heart Federation … Updated October 2008 Diagnosis and Management of Acute Rheumatic Fever and Rheumatic Heart Disease.
WHSSC REFERRAL MANAGEMENT
Introduction to the Summary Care Record (SCR) GP Module SCR Concept Training GP Module Self Run v
Local Improvement following National Clinical Audit The View from a National Clinical Audit Provider – the Health & Social Care Information Centre.
Instructions and Reporting Requirements Module 3 Electronic Reporting For Facilities March 2014 North Carolina Central Cancer Registry State Center for.
Specifying clinical IT requirements for pathways: a national perspective Dr Mark Dancy Consultant Cardiologist National Clinical Lead CHD Collaborative.
Biologics for Children with Rheumatic Diseases An Introduction.
1 Cohort management and the Secondary Uses Service (SUS) Nirupa Dattani Office for National Statistics.
NPCA data submission and reporting
EUROCHIP Pilot Study Dr. Finian Bannon Dr. Anna Gavin N. Ireland Cancer Registry Waiting Times & Compliance with Guidelines UK.
West Midlands Cancer Intelligence Unit Extending Quality Assurance to all Breast Cancers: the BCCOM Project UKACR Annual Conference 29 September 2004 Gill.
March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.
Tumour Matching N.Ireland Experience Colin Fox (IT Manager) Richard Middleton (Data Manager)
Taxanes for Ovarian Cancer: Progress Report Rosemary Tate Information Projects Team December 2000.
National Cancer Registry Luxembourg EUROCHIP-3 Meeting Ispra, 27 th February 2012 Olivier Collignon, PhD, Sophie Couffignal, MD, CRP-Santé.
The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.
ISB Notice and preparing for the implementation of the new IAPT Data Standard Shaun Crowe Mental Health, Employment and IAPT Mental Health Collaborative.
Evaluation of Electronic Radiotherapy Data for Quality Checking Cancer Registry Data Colin Fox (NICR) Richard Middleton (NICR) Denise Lynd (BCH – COIS)
Selection of Data Sources for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Automated Cancer Registration N.Ireland Experience Colin Fox (IT Manager) Richard Middleton (Data Manager)
Gayle Greer Clutter, R.T., CTR Program Consultant
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Kent & Medway Cancer Network Thames Cancer Registry Cancer Registration Dataset Pilot Nigel Brook.
National Bowel Cancer Audit Clinical Audit Platform How to Register, Submit and View Reports CAP:
RARECARENet project High-resolution study in the Finnish Cancer Registry Maarit Leinonen Chief Medical Officer Finnish Cancer Registry, Helsinki.
Annual Informatics Meeting Changes to the Renal Registry Dataset Fiona Braddon Clinical Informatics Manager.
NATIONAL CANCER REGISTRY IRELAND. Basic registration dataset Patient dataCancer dataTreatment and follow up registration numbertumour idtreatment id year.
National Oesophago-Gastric Cancer Audit Clinical Audit Platform How to Register, Submit and View Reports CAP: |
Measuring progress towards delivery of the target Ken Nicholson, ISD.
Radiotherapy Data Collection Helen Forbes National Cancer Services Analysis Team.
Evaluation of routine data sources for ascertainment of hypospadias cases Congenital Anomaly Register for Oxfordshire, Berkshire, and Buckinghamshire (CAROBB)
The NHS Constitution: A consultation on new patient rights.
An Outline of Automated Cancer Registration Chris Carrigan National Coordinator for Cancer Registration in England For the Automated Cancer Registration.
Publication / Fit for Purpose Kirsty Anderson Principal Information Analyst.
The Health Roundtable Improving data collection rates, while improving quality Presenter: Sandra Avery Liverpool Innovation Poster Session HRT1215 – Innovation.
Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN.
Gynaecology MDT Coordinator
NECN Colorectal NSSG Audit of Waiting Times for Lower GI Cancer Patients in NECN April 2010 – March 2011.
Carlos Rocha Registry Manager National Cancer Registration Service (South West) West Dean Registration Improvement of Non-Melanoma skin cancer.
Dr Heather O Dickinson My web page Department of Child Health University of Newcastle My web page Audit of cancer registrations notified by National Health.
Vicki LaRue, CTR KCR Abstractor’s Training February 12,
How clinicians use data to make an impact on clinical outcomes Andrew Brodbelt Consultant Neurosurgeon and Clinical Director of Neurosurgery, The Walton.
The management of low-risk basal cell carcinomas in the community Implementing NICE guidance in general practice May 2010 NICE guidance on cancer services.
Cancer Outcomes and Services Dataset What is COSD? Implications for Providers and Networks.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
Two-week wait referrals for malignant melanoma: A clinical audit carried out across four UK Cancer Networks South West Cancer Intelligence Service
Routes to Diagnosis of Cancer in London, Katherine Henson, NCRAS, Presentation for London Public Health Knowledge and Intelligence Network.
Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.
TRIAL PARTICIPATION IN THE OVER 60s: A RE-AUDIT OF THE MANAGEMENT OF AML IN THE SOUTH WEST OF ENGLAND South West Cancer Intelligence Service
Treatment Capture from Follow Back to Oncology Offices by Frances Ross Presented at the 2013 NAACCR Annual Conference Austin, TX.
What data are collected? How, and who by?. It’s complicated… ONS data.
South East Public Health Observatory Hospital Episodes Statistics (HES) Steve Morgan - Senior Public Health Intelligence Analyst - SEPHO Day 2 – Session.
A ssociation of Public Health Observatories Hospital Activity data Roy Maxwell SWPHO & Bristol University Dr Richard Wilson Sandwell PCT.
2 November John Childs and Deborah Woodley
National Bowel Cancer Audit
Oesophago–Gastric Cancer
Segmented analysis of prostate cancer pathway from referral to treatment: This work was carried out in partnership between the Transforming.
Somerset Cancer Register
Segmented analysis of the lung cancer median pathway from referral to treatment: This work was carried out in partnership between the Transforming.
Genomic Medicine Centre Overview
Genomic Medicine Centre Overview
Breast Cancer SSG 14th November
28 Day Faster Diagnosis Standard
Comparing the multiple sources of cancer treatment data
Dataset Description Time Period Accident & Emergency
Presentation transcript:

Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September How useful is the Cancer Waiting Times (CWT) dataset for the purposes of cancer registration? - a data quality and evaluation exercise at NYCRIS. Caroline Brook Information Services Manager, NYCRIS

Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September Introduction CWT dataset defined in 2002 for monitoring waiting times (against targets identified in the NHS Cancer Plan). DSCN 22/2002 mandated data collection by Trusts. National guidance on data collection and data definitions. Data held nationally on a central database. All data items are included in the National Cancer Dataset. April replaced the existing paper-based monitoring arrangements (QMCW).

Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September What does the CWT dataset contain? All urgently referred patients with suspected cancer. All confirmed cases of cancer (whether urgently referred or not). Extended to cover all sites of cancer from September What it does not contain… “All sites of cancer” for CWT does not equal “All registerable conditions” for cancer registries. Patients who die prior to receiving treatment. Private patients. Patients who do not have an NHS number.

Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September The work at NYCRIS Project to examine how this source of data could be used for purposes of cancer registration. Identified one pilot Acute Trust from each of four cancer networks (3 cancer units and 1 cancer centre). Data were obtained directly from each Trust (as central feed from the CWT database to registries was not yet established). Objectives were to evaluate usefulness for cancer registration and to provide feedback to Trusts on data quality and ascertainment.

Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September Method Trusts extracted confirmed cases of cancer with one or more of 3 specified dates between 01/01/04 and 31/03/ records in total. (31% via the urgent referral route.) NYCRIS notifications had been processed for this period. All records were matched using NYCRIS patient matching utility against the whole of the registration database. Records matching at patient level were then matched at tumour level using 3-digit ICD-10 codes. NYCRIS also identified a cohort of relevant cases from its registration database in order to identify any cases potentially missing from the CWT extracts.

Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September Results - patient matching 1562 records matched at patient level against the whole of of the NYCRIS database. a 90% electronic patient match rate. 167 were manually reviewed resulting in a further 48 patient matches. Reasons for non-matches electronically were largely due to incorrectly typed patient demographics, or registrations made since matching taken place. 119 of the non-matched patients were identified as potential new registrations. These included cases with previously missed pathology, clinical diagnoses and advanced disease.

Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September Results - tumour matching 1283 records matched on tumour (out of a possible 1570) (3 digit ICD-10, either outside or within the identified cohort). an 82% electronic tumour match rate. 140 of the unmatched tumours have been manually reviewed resulting in 132 being matched. This can be due to recording of secondary sites by NYCRIS prior to full investigation, but largely due to differences in recording of in-situ cases (bladder, breast, skin). 7 of the unmatched tumours reviewed resulted in possible new registrations.

Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September Results - NYCRIS cohort 550 cases identified by NYCRIS as highly likely to have been included in the CWT extracts were not matched. (CWT sites only, pathology confirmed cases only, death notifications excluded, etc.). 85 of these have been reviewed manually by one of the participating Trusts. – 55 have been identified on the Trust database but not yet uploaded on the CWT database, 11 were private patients. – The Trust had no record of 8 of the patients and the remaining 11 were queried by them with regard to site or diagnosis date.

Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September Advantages for cancer registration Earlier notification of clinically diagnosed cases. Identifies any cases where pathology reports gone missing. Provision of additional data items to add to existing notifications, i.e. postcode (98%), NHS number (100%), known registered PCT (93%), details of first treatment (provider, treatment type, treatment date) (99%). May provide a more specific site to previously registered secondaries. This leads to more complete provisional registrations and faster case ascertainment.

Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September Limitations for cancer registration CWT data only cover 71% of all registerable conditions. Patient not included if dies prior to treatment or treated privately. Only 3 digit ICD-10 site code and no morphology code, therefore more difficult to carry-out precise tumour matching. Patients excluded who have no NHS number, therefore low ascertainment for patients on Scottish border. Could lead to over-registration of malignant sites if not matched with pathology. First treatment date for surgery = date of admission.

Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September Lessons learned For Trusts Duplicate CWT entries identified where patients are referred to one provider and treated at another. Missing cases identified by registry - helps to inform process for picking up non-urgently referred cases. Need to improve identification of in-situs. For NYCRIS Inaccurate data-entry of demographics reducing patient-matching. Some inadequacies in current pathology notification processes. A CWT record can provide sufficient information to make an initial notification (but not a provisional registration).

Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September Conclusion CWT dataset is a useful early source of initial notification for cancer registries but does not cover all required cases. Additional data items could be obtained early in the process. When combined with other notifications, i.e. pathology, it can make a more complete provisional registration. Registries need to work with Trusts to improve their coding and ascertainment of cases to make it even more reliable. Consideration given to which date(s) to use for extract and a rolling programme established to ensure no missed cases.